Sjögren and Gynecologic Considerations
NCT05670535 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 118
Last updated 2023-01-04
Summary
Sjögren's syndrome is an autoimmune disorder characterized by glandular and extra-glandular manifestations. It is called primary Sjögren's syndrome (pSS) in absence of another connective tissue disease. The hallmark symptoms of pSS are dry eyes and dry mouth due to the decreased lacrimal and salivary gland functions. However, other tissue and organs may also be involved which precede such as xerotrachea in upper airway, atrophic gastritis and pancreatitis in gastrointestinal tract, and dryness in vaginal mucosa.
Regarding to the genital involvement in pSS, vaginal dryness and resultant vaginal discomfort, and pain are reported as the common complaints. The transudate released by vaginal mucosa is the main resource of vaginal secretions.The human microbiome was reported to have a potential impact in etiopathogenesis of certain autoimmune disorders. The previous research revealed significant alterations in the gut, eye, and oral flora of the pSS patients. The disturbed oral flora due to immunodeficiency and reduced salivary flow was also reported to make the SS patients to prone to bacterial infections and recurrent oral candidiasis. Vaginitis has been defined as a spectrum of symptoms suggesting vulvovaginal discomfort such as itching, burning, irritation, and abnormal discharge. Even the vaginitis is an evidence of disturbance in vaginal flora, previous prospective research on vaginal microbiome of pSS patients either excluded the cases with vaginitis or not mentioned from the presence of vaginitis in women with pSS. To the best of our knowledge, there has not been any study yet to define the characteristics of vaginal flora through the presence of clinical signs and symptoms in women with pSS. To gain more insight into the clinical context of the gynecologic complaints, sexual dysfunction, and presence of vaginitis in pSS, the current study aims to identify the associations between these issues and pSS related disease parameters.
Conditions
- Primary Sjögren Syndrome
- Vaginitis Candida
- Vaginitis
- Sexual Dysfunction
Interventions
- OTHER
-
Visual analogue scale (VAS) for dyspareunia
Dyspareunia scores between 0 to 10 points
- OTHER
-
Visual analogue scale (VAS) for vaginal dryness
Vaginal dryness scores between 0 to 10 points
- OTHER
-
The European League Against Rheumatism Sjögren's Syndrome Disease Activity Index (ESSDAI)
Sjögren's Syndrome Disease Activity Index scores between 0 to 3 points
- OTHER
-
The European League Against Rheumatism Sjögren's Syndrome Patient Reported Index (ESSPRI)
Sjögren's Syndrome Patient Reported Index scores between 0 to 10 points
Sponsors & Collaborators
-
Ankara City Hospital Bilkent
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2022-10-15
- Completion
- 2022-11-10
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Cytokines and the Risk of Infection in Liver Cirrhosis
NCT00857181 ·Status: TERMINATED
-
Quantification and Characterization of Circulating Epithelial and Endothelial Cells in Gougerot-Sjögren Syndrome, Compared to Systemic Sclerosis
NCT05528809 ·Status: COMPLETED ·Phase: NA
-
Changes in Natural Immunity in Pregnant Women With Autoimmune Thyroid Disease
NCT06925399 ·Status: NOT_YET_RECRUITING
-
Autoantibodies and Direct-acting Antivirals
NCT03566966 ·Status: COMPLETED
-
Study of Populations at Risk of Developing Chronic Hepatitis Linked to Chronic Enteric Virus Infection in Patients With Primary Immunodeficiency and Secondary Humoral Deficiency
NCT06659588 ·Status: RECRUITING
-
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
NCT07146906 ·Status: RECRUITING ·Phase: PHASE2
-
Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
NCT01195987 ·Status: UNKNOWN
-
Serum Regucalcin Level and Chronic Hepatitis B
NCT05435599 ·Status: COMPLETED ·Phase: NA
-
Salivary Immunoglobulin A (sIgA) Normal Range Study
NCT06248788 ·Status: COMPLETED
-
Biomarkers for the Progression of IgA Nephropathy
NCT02529722 ·Status: COMPLETED
-
Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis
NCT05473403 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
H-pylori Infection With Disease Activity in Systemic Lupus Erythematosus and Rheumatoid Arthritis
NCT06586567 ·Status: NOT_YET_RECRUITING
-
Prevalence of Hepatitis c Virus Infection Among Rheumatological Patients
NCT03587714 ·Status: COMPLETED
-
TruGraf Liver Gene Expression Serial Test
NCT06061341 ·Status: ENROLLING_BY_INVITATION
-
A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)
NCT04163016 ·Status: COMPLETED ·Phase: PHASE1
-
Syndecan 1 as Biomarker for Inflammation
NCT02333526 ·Status: UNKNOWN
-
Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
NCT01672164 ·Status: COMPLETED
-
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
NCT02257866 ·Status: RECRUITING
-
Pattern of Autoimmune Hepatitis in Children In Sohag University Hospital
NCT06020976 ·Status: UNKNOWN
-
Therapeutic Effect of Hydroxychloroquine on Immunoglobulin A (IgA) Nephropathy Course QUIgAN Study
NCT06350630 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Tregs CD25 CXCL9 in Vitiligo
NCT05569096 ·Status: NOT_YET_RECRUITING
-
Frequency and Risk Factors for Autoimmune Disorders and Rheumatic Manifestations in Egyptian Patients With IBD
NCT05771363 ·Status: UNKNOWN
-
Association Between Hidradenitis Suppurativa and Spondyloarthritis
NCT03668925 ·Status: COMPLETED ·Phase: NA
-
PredIcting SterOid DepeNdEnt LivEr InjuRy with Polyreactive Immunoglobulin G
NCT05810480 ·Status: RECRUITING
-
Understanding the Role of Oral Microbiota in Behçet's Disease (BEHCETBIOT)
NCT04959435 ·Status: COMPLETED